Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes
on page 1 showing 20 out of 555 results from 1 sources
http://web.expasy.org/cellosaurus/CVCL_9T08

Cite this IZSLER Cat# BS CL 159, RRID:CVCL_9T08
Organism: Homo sapiens
Disease:
Category: Finite cell line
Comment:

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0284

Cite this IZSLER Cat# BS TCL 136, RRID:CVCL_0284
Organism: Rattus norvegicus
Disease: Rat hepatocellular carcinoma
Category: Cancer cell line
Comment: Discontinued: ATCC; CRL-9185. Breed/subspecies: AxC.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0301

Cite this IZSLER Cat# BS TCL 188, RRID:CVCL_0301
Organism: Mesocricetus auratus
Disease:
Category: Transformed cell line
Comment: Doubling time: 33-34 hours (PubMed=6270673). Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0163

Cite this IZSLER Cat# BS TCL 145, RRID:CVCL_0163
Organism: Mus musculus
Disease: Mouse neoplasms
Category: Cancer cell line
Comment: Doubling time: ~70 hours (DSMZ). Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU). Breed/subspecies: C3H.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0145

Cite this IZSLER Cat# BS CL 193, RRID:CVCL_0145
Organism: Homo sapiens
Disease:
Category: Spontaneously immortalized cell line
Comment: Doubling time: 55 hours (from cell counting), 65 hours (from absorbance) (DOI=10.5897/IJBMBR2013.0154). Omics: Transcriptome analysis.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_2321

Cite this IZSLER Cat# BS CL 11, RRID:CVCL_2321
Organism: Homo sapiens
Disease:
Category: Finite cell line
Comment:

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_2886

Cite this IZSLER Cat# BS CL 25, RRID:CVCL_2886
Organism: Cricetulus griseus
Disease:
Category: Spontaneously immortalized cell line
Comment:

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_4154

Cite this IZSLER Cat# BS CL 126, RRID:CVCL_4154
Organism: Oncorhynchus kisutch
Disease:
Category: Spontaneously immortalized cell line
Comment: Group: Fish cell line.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_W669

Cite this IZSLER Cat# BS CL 167, RRID:CVCL_W669
Organism: Homo sapiens
Disease:
Category: Telomerase immortalized cell line
Comment: Transfected with: HGNC; 11730; TERT.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0002

Cite this IZSLER Cat# BS TCL 25, RRID:CVCL_0002
Organism: Homo sapiens
Disease: Adult acute myeloid leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 3. Part of: MD Anderson Cell Lines Project. Part of: MYC genetic alteration cell panel (ATCC TCP-1035). Registration: National Institute of Standards and Technology, Standard Reference Materials; SRM 2392-I. Biotechnology: Used a source of mitochondrial DNA for USA forensic testing. Doubling time: 28 hours (PubMed=25984343); ~40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger). Sequence variation: Homozygous for CDKN2A p.Arg80Ter (PubMed=17088437). Sequence variation: Heterozygous for NRAS p.Gln61Leu (PubMed=17088437). Omics: Cell surface proteome. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: Mitochondrial genome sequenced. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: Occasionally 'IIL-60'.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0004

Cite this IZSLER Cat# BS TCL 33, RRID:CVCL_0004
Organism: Homo sapiens
Disease: Chronic myelogenous leukemia, BCR-ABL1 positive
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 1. Part of: MD Anderson Cell Lines Project. Part of: NCI60 cancer cell line panel. Doubling time: 47 hours (PubMed=25984343); 19.6 hours (NCI-DTP); ~30-40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=23671654; Sanger). Sequence variation: Homozygous for TP53 p.Gln136fs*13 (PubMed=17088437; PubMed=18277095). Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: H3K27me3 ChIP-seq epigenome analysis. Omics: H3K36me3 ChIP-seq epigenome analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K9ac ChIP-seq epigenome analysis. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using proteomics. Misspelling: 'K-652' in Cosmic 1523829. Misspelling: 'K652' in Cosmic 1516632 and Cosmic 2024372.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0006

Cite this IZSLER Cat# BS TCL 138, RRID:CVCL_0006
Organism: Homo sapiens
Disease: Childhood acute monocytic leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: MD Anderson Cell Lines Project. Part of: RAS genetic alteration cell panel (ATCC TCP-1031). Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981). Characteristics: Can differentiate from monocytes into macrophage-like cells upon stimulation with PMA. Doubling time: 26 hours (PubMed=25984343); ~35-50 hours (DSMZ). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Heterozygous for NRAS p.Gly12Asp (ATCC). Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep promoter analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Glycoproteome analysis by proteomics. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Derived from sampling site: Peripheral blood.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0007

Cite this IZSLER Cat# BS TCL 73, RRID:CVCL_0007
Organism: Homo sapiens
Disease: Adult acute monocytic leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Characteristics: Can be induced to differentiate into macrophages by several factors such as phorbol ester (PMA) and 12-O-tetradecanoyl-13-phorbol acetate (TPA). Doubling time: 95-100 hours (PubMed=178611); ~30-40 hours (DSMZ). Omics: Deep antibody staining analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Proteome analysis by 2D-DE/MS. Omics: SNP array analysis. Omics: Transcriptome analysis. Discontinued: ATCC; CRL-1593. Discontinued: RCB; RCB1978.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0013

Cite this IZSLER Cat# BS TCL 85, RRID:CVCL_0013
Organism: Homo sapiens
Disease: Adult T acute lymphoblastic leukemia
Category: Cancer cell line
Comment: Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel. Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: MD Anderson Cell Lines Project. Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel. Part of: NCI60 cancer cell line panel. Doubling time: 31.56 +- 1.488 hours (PubMed=24762992); 33 hours (PubMed=17117183); 29 hours (PubMed=20922763); 27.9 hours (NCI-DTP); ~40 hours (DSMZ). Microsatellite instability: Instable (MSI-high) (Sanger). Sequence variation: Heterozygous for NRAS p.Gly12Cys (PubMed=17088437). Sequence variation: Homozygous for PTEN p.Lys267fs*9 (PubMed=17088437). Sequence variation: Heterozygous for STK11 p.Gln214Ter (PubMed=17088437). Sequence variation: Heterozygous for TP53 p.Arg306Ter (PubMed=17088437). Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0008

Cite this IZSLER Cat# BS TCL 104, RRID:CVCL_0008
Organism: Homo sapiens
Disease: Epstein-Barr virus-related Burkitt lymphoma
Category: Cancer cell line
Comment: Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel. Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: Human variation panel. Part of: MD Anderson Cell Lines Project. Population: Africans south of the Sahara. Doubling time: ~48 hours (DSMZ). Microsatellite instability: Instable (MSI-low) (Sanger). Sequence variation: TP53 p.Arg213Ter (PubMed=2052620). Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV). Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using RNAseq.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0137

Cite this IZSLER Cat# BS CL 162, RRID:CVCL_0137
Organism: Rattus norvegicus
Disease:
Category: Spontaneously immortalized cell line
Comment: Breed/subspecies: BDIX.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0335

Cite this IZSLER Cat# BS CL 136, RRID:CVCL_0335
Organism: Homo sapiens
Disease:
Category: Finite cell line
Comment: AS CVCL_0710

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0014

Cite this IZSLER Cat# BS TCL 92, RRID:CVCL_0014
Organism: Homo sapiens
Disease: Plasma cell myeloma
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: MD Anderson Cell Lines Project. Part of: NCI60 cancer cell line panel. Doubling time: 60 hours (PubMed=25984343); 33.5 hours (NCI-DTP); ~60-70 hours (DSMZ). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Heterozygous for EGFR p.Thr751Ile (PubMed=17088437). Sequence variation: Heterozygous for KRAS p.Gly12Ala (PubMed=17088437). Sequence variation: Homozygous for TP53 p.Glu285Lys; temperature-sensitive (PubMed=17088437; PubMed=18277095). Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: Occasionally 'RPMI-8266'. Misspelling: 'RPMI-8826' in Cosmic 875867. Derived from sampling site: Peripheral blood.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0019

Cite this IZSLER Cat# BS TCL 232, RRID:CVCL_0019
Organism: Homo sapiens
Disease: Neuroblastoma
Category: Cancer cell line
Comment: Problematic cell line: Partially contaminated. Some laboratories that are redistributing this cell line are in fact redistributing a contaminated cell line of mouse origin (PubMed=25182563). Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 3. From: Memorial Sloan-Kettering Cancer Center; New York; USA. Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK 810. Doubling time: >55 hours (DSMZ). Sequence variation: ALK p.Phe1174Leu (PubMed=28350380). Omics: Deep antibody staining analysis. Omics: Deep RNAseq analysis. Omics: GPI-anchored proteins analysis by proteomics. Omics: Mitochondrial proteome analysis by 2D-DE/MS. Omics: N-glycan profiling. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: Occasionally 'SH-SY5'. Derived from metastatic site: Bone marrow.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0022

Cite this IZSLER Cat# BS TCL 189, RRID:CVCL_0022
Organism: Homo sapiens
Disease: Glioblastoma
Category: Cancer cell line
Comment: Problematic cell line: Contaminated/misidentified. This cell line is not the original glioblastoma cell line established in 1968 at the University of Uppsala. As described in PubMed=27582061 it is most probably also a glioblastoma cell line but whose origin is unknow. See U-87MG Uppsala (CVCL_GP63) for the original U-87MG cell line. Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 3. Doubling time: 72 hours (PubMed=25984343). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Has no IDH1 mutation (PubMed=19435942). Omics: Cell surface proteome. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Genome sequenced. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Discontinued: RCB; RCB0419.

  • From Current Category

  1. Resource Identification Portal Resources

    Welcome to the RRID Resources search. From here you can search through a compilation of resources used by RRID and see how data is organized within our community.

  2. Navigation

    You are currently on the Community Resources tab looking through categories and sources that RRID has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.

  3. Logging in and Registering

    If you have an account on RRID then you can log in from here to get additional features in RRID such as Collections, Saved Searches, and managing Resources.

  4. Searching

    Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:

    1. Use quotes around phrases you want to match exactly
    2. You can manually AND and OR terms to change how we search between words
    3. You can add "-" to terms to make sure no results return with that term in them (ex. Cerebellum -CA1)
    4. You can add "+" to terms to require they be in the data
    5. Using autocomplete specifies which branch of our semantics you with to search and can help refine your search
  5. Save Your Search

    You can save any searches you perform for quick access to later from here.

  6. Query Expansion

    We recognized your search term and included synonyms and inferred terms along side your term to help get the data you are looking for.

  7. Collections

    If you are logged into RRID you can add data records to your collections to create custom spreadsheets across multiple sources of data.

  8. Sources

    Here are the sources that were queried against in your search that you can investigate further.

  9. Categories

    Here are the categories present within RRID that you can filter your data on

  10. Subcategories

    Here are the subcategories present within this category that you can filter your data on

  11. Further Questions

    If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.

X